<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments for HCA Cancer Care</title>
	<atom:link href="http://blog.hcacancercare.co.uk/comments/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.hcacancercare.co.uk</link>
	<description>World class expertise. Closer to you.</description>
	<lastBuildDate>Thu, 24 Jun 2010 08:52:48 +0000</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>Comment on UK’s first private Molecular Imaging Centre at The Harley Street Clinic by HCA Cancer Care</title>
		<link>http://blog.hcacancercare.co.uk/latest-technology/uk%e2%80%99s-first-private-molecular-imaging-centre-at-the-harley-street-clinic/comment-page-1/#comment-137</link>
		<dc:creator>HCA Cancer Care</dc:creator>
		<pubDate>Thu, 24 Jun 2010 08:52:48 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hcacancercare.co.uk/?p=40#comment-137</guid>
		<description>FDG stands for fluorodeoxyglucose and is a glucose analogue.  It is attached to radioactive Flourine 18.  It is this product when injected into a patient enables the PET/CT scanner to visualize the uptake of the glucose analogue so that the function/ disease status of specific organs or tissues in the body can be demonstrated due to the increased uptake of the tracer in areas of raised glucose metabolism. 

Please let us know if this answers your question and if you have any further queries.</description>
		<content:encoded><![CDATA[<p>FDG stands for fluorodeoxyglucose and is a glucose analogue.  It is attached to radioactive Flourine 18.  It is this product when injected into a patient enables the PET/CT scanner to visualize the uptake of the glucose analogue so that the function/ disease status of specific organs or tissues in the body can be demonstrated due to the increased uptake of the tracer in areas of raised glucose metabolism. </p>
<p>Please let us know if this answers your question and if you have any further queries.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on HCA CancerCare launches hospital blog by Simon Rivers</title>
		<link>http://blog.hcacancercare.co.uk/news/hca-cancercare-launches-hospital-blog/comment-page-1/#comment-10</link>
		<dc:creator>Simon Rivers</dc:creator>
		<pubDate>Wed, 14 Apr 2010 13:34:49 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hcacancercare.co.uk/?p=3#comment-10</guid>
		<description>On behalf of the network team I&#039;d like to welcome you to the HCA CancerCare Blog. Please feel free to contact me and my senior team colleagues:
Simon Rivers, Network Manager (simon.rivers@hcahealthcare.co.uk)
Cathy Demosthenous, Network Manager (cathy.demosthenous@hcahealthcare.co.uk)
Vesna Hogan, Cancer Informatics Lead (vesna.hogan@hcahealthcare.co.uk)

Tel +44 (0)20 7034 8873</description>
		<content:encoded><![CDATA[<p>On behalf of the network team I&#8217;d like to welcome you to the HCA CancerCare Blog. Please feel free to contact me and my senior team colleagues:<br />
Simon Rivers, Network Manager (simon.rivers@hcahealthcare.co.uk)<br />
Cathy Demosthenous, Network Manager (cathy.demosthenous@hcahealthcare.co.uk)<br />
Vesna Hogan, Cancer Informatics Lead (vesna.hogan@hcahealthcare.co.uk)</p>
<p>Tel +44 (0)20 7034 8873</p>
]]></content:encoded>
	</item>
</channel>
</rss>

